A Day Up For Jounce Therapeutics, Inc.

Wed, Dec 28, 2022 at 07:05 PM
A Day Up For Jounce Therapeutics, Inc.

Jounce Therapeutics, Inc. (JNCE:NASDAQ) rocketted at $0.99, a gain of 33.8%. On Wed, Dec 28, 2022, JNCE:NASDAQ touched a New 2-Week High of $0.99. The stock appeared on our News Catalysts scanner on Wed, Dec 28, 2022 at 11:31 AM in the 'BIOTECH' category. From Wed, Dec 14, 2022, the stock recorded 55.56% Up Days and 50.00% Green Days

The stock spiked on Wed, Dec 28, 2022 at $1.27 with a volume of 37M+.

About Jounce Therapeutics, Inc. (JNCE:NASDAQ)

Jounce Therapeutics Inc is a clinical stage immunotherapy company. It is engaged in transforming the treatment pf cancer by developing therapies that enable the immune system to attack tumors and provide long-lasting benefits to patients.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.